CLINICAL_TRIALS
trial_result
· 2018-10-30
Clinical Trial Update: Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men [Phase 3]
Summary
Open-label Phase 3 follow-up study of oral testosterone undecanoate in men with hypogonadism.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Clarus Therapeutics, Inc. | Conditions: Male Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2018-10-30